| “Obesity and insulin resistance” is the component of the metabolic syndrome most strongly associated with oxidative stress GK Jakubiak, K Osadnik, M Lejawa, T Osadnik, M Goławski, ... Antioxidants 11 (1), 79, 2021 | 89 | 2021 |
| Oxidative stress in association with metabolic health and obesity in young adults GK Jakubiak, K Osadnik, M Lejawa, S Kasperczyk, T Osadnik, N Pawlas Oxidative Medicine and Cellular Longevity 2021 (1), 9987352, 2021 | 85 | 2021 |
| Pathogenesis and clinical significance of in-stent restenosis in patients with diabetes GK Jakubiak, N Pawlas, G Cieślar, A Stanek International Journal of Environmental Research and Public Health 18 (22), 11970, 2021 | 82 | 2021 |
| Endothelial function assessment by flow-mediated dilation method: a valuable tool in the evaluation of the cardiovascular system S Mućka, M Miodońska, GK Jakubiak, M Starzak, G Cieślar, A Stanek International journal of environmental research and public health 19 (18), 11242, 2022 | 74 | 2022 |
| Chronic lower extremity ischemia and its association with the frailty syndrome in patients with diabetes GK Jakubiak, N Pawlas, G Cieślar, A Stanek International Journal of Environmental Research and Public Health 17 (24), 9339, 2020 | 51 | 2020 |
| Nitrotyrosine, nitrated lipoproteins, and cardiovascular dysfunction in patients with type 2 diabetes: What do we know and what remains to be explained? GK Jakubiak, G Cieślar, A Stanek Antioxidants 11 (5), 856, 2022 | 46 | 2022 |
| A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults T Osadnik, M Goławski, P Lewandowski, J Morze, K Osadnik, N Pawlas, ... Pharmacological Research 183, 106402, 2022 | 44 | 2022 |
| Arterial stiffness assessment by pulse wave velocity in patients with metabolic syndrome and its components: is it a useful tool in clinical practice? M Starzak, A Stanek, GK Jakubiak, A Cholewka, G Cieślar International Journal of Environmental Research and Public Health 19 (16), 10368, 2022 | 43 | 2022 |
| Cardiac troponin serum concentration measurement is useful not only in the diagnosis of acute cardiovascular events GK Jakubiak Journal of Personalized Medicine 14 (3), 230, 2024 | 22 | 2024 |
| Comparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis J Morze, T Osadnik, K Osadnik, M Lejawa, G Jakubiak, N Pawlas, ... BMJ open 10 (8), e032755, 2020 | 10 | 2020 |
| Retrospective cross-sectional study of the relationship of thyroid volume and function with anthropometric measurements, body composition analysis parameters, and the diagnosis … GK Jakubiak, N Pawlas, M Morawiecka-Pietrzak, M Starzak, A Stanek, ... Medicina 60 (7), 1080, 2024 | 8 | 2024 |
| Life-threatening endocrinological immune-related adverse events of immune checkpoint inhibitor therapy A Basek, GK Jakubiak, G Cieślar, A Stanek Cancers 15 (24), 5786, 2023 | 8 | 2023 |
| Genetically determined metabolism of nicotine and its clinical significance M Delijewski, A Bartoń, P Delijewska, R Balwierz, G Jakubiak, L Kośmider, ... Acta Biochimica Polonica 66 (4), 375-381, 2019 | 8 | 2019 |
| Physical Activity Modifies the Severity of COVID-19 in Hospitalized Patients—Observational Study E Sutkowska, A Stanek, K Madziarska, GK Jakubiak, J Sokołowski, ... Journal of Clinical Medicine 12 (12), 4046, 2023 | 7 | 2023 |
| A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults., 2022, 183 T Osadnik, M Goławski, P Lewandowski, J Morze, K Osadnik, N Pawlas, ... DOI: https://doi. org/10.1016/j. phrs, 106402, 2022 | 5 | 2022 |
| Gastrointestinal symptoms in the course of COVID-19 GK Jakubiak, J Ochab-Jakubiak, G Cieślar, A Stanek Postepy Hig. Med. Dosw 74, 498-503, 2020 | 5 | 2020 |
| A network meta-analysis on the comparative efficacy of nutraceuticals on lipid profile J Morze, T Osadnik, K Osadnik, M Lejawa, G Jakubiak, N Pawlas, ... Circulation 140 (Suppl_1), A13360-A13360, 2019 | 5 | 2019 |
| Zasady leczenia farmakologicznego dny moczanowej G Jakubiak Lek w Polsce 26 (300), 6-13, 2016 | 4 | 2016 |
| Lomitapid - właściwości farmakologiczne i zastosowanie kliniczne GK Jakubiak Gabinet Prywatny 23 (249-250), 50-56, 2016 | 3 | 2016 |
| Inhibitory PCSK9 - nowy kierunek farmakoterapii dyslipidemii G Jakubiak Lek w Polsce 26 (298-299), 70-76, 2016 | 3 | 2016 |